Shift4 Payments Valuation
Is FOUR * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of FOUR * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: FOUR * (MX$1015) is trading below our estimate of fair value (MX$1503.58)
Significantly Below Fair Value: FOUR * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for FOUR *?
Other financial metrics that can be useful for relative valuation.
What is FOUR *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$5.18b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.1x |
Enterprise Value/EBITDA | 15.4x |
PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does FOUR *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 21.8x | ||
GENTERA * Gentera. de | 8.7x | 16.3% | Mex$42.1b |
INVEX A INVEX Controladora. de | 10.4x | n/a | Mex$13.4b |
STNE StoneCo | 16.6x | 18.6% | US$5.2b |
GBM O Corporativo GBM. de | 51.6x | n/a | Mex$22.0b |
FOUR * Shift4 Payments | 43.2x | 34.0% | Mex$5.2b |
Price-To-Earnings vs Peers: FOUR * is expensive based on its Price-To-Earnings Ratio (43.2x) compared to the peer average (21.8x).
Price to Earnings Ratio vs Industry
How does FOUR *'s PE Ratio compare vs other companies in the South American Diversified Financial Industry?
Price-To-Earnings vs Industry: FOUR * is expensive based on its Price-To-Earnings Ratio (43.2x) compared to the South American Diversified Financial industry average (8.6x).
Price to Earnings Ratio vs Fair Ratio
What is FOUR *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 43.2x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate FOUR *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,015.00 | Mex$1,501.41 +47.9% | 12.7% | Mex$1,774.99 | Mex$895.95 | n/a | 21 |
May ’25 | n/a | Mex$1,523.72 0% | 12.4% | Mex$1,797.43 | Mex$907.28 | n/a | 22 |
Apr ’25 | Mex$1,135.00 | Mex$1,501.97 +32.3% | 12.2% | Mex$1,739.23 | Mex$866.63 | n/a | 23 |
Mar ’25 | n/a | Mex$1,554.67 0% | 12.5% | Mex$1,790.04 | Mex$891.95 | n/a | 23 |
Feb ’25 | n/a | Mex$1,467.64 0% | 16.3% | Mex$1,892.44 | Mex$854.01 | n/a | 22 |
Jan ’25 | n/a | Mex$1,359.80 0% | 17.1% | Mex$1,886.78 | Mex$834.98 | n/a | 21 |
Dec ’24 | n/a | Mex$1,342.64 0% | 12.3% | Mex$1,670.82 | Mex$1,033.49 | n/a | 19 |
Nov ’24 | n/a | Mex$1,407.22 0% | 13.8% | Mex$1,751.19 | Mex$992.94 | n/a | 19 |
Oct ’24 | n/a | Mex$1,406.42 0% | 10.9% | Mex$1,656.12 | Mex$973.18 | n/a | 16 |
Sep ’24 | n/a | Mex$1,399.06 0% | 12.0% | Mex$1,675.52 | Mex$955.05 | n/a | 18 |
Aug ’24 | Mex$1,150.95 | Mex$1,375.99 +19.6% | 12.0% | Mex$1,632.38 | Mex$841.44 | n/a | 17 |
Jul ’24 | n/a | Mex$1,395.23 0% | 11.9% | Mex$1,665.68 | Mex$858.60 | n/a | 16 |
Jun ’24 | n/a | Mex$1,442.66 0% | 12.8% | Mex$1,724.59 | Mex$888.97 | n/a | 14 |
May ’24 | n/a | Mex$1,471.78 0% | 12.8% | Mex$1,744.05 | Mex$899.00 | n/a | 14 |
Apr ’24 | n/a | Mex$1,463.08 0% | 17.4% | Mex$1,806.24 | Mex$651.74 | Mex$1,135.00 | 14 |
Mar ’24 | n/a | Mex$1,390.30 0% | 17.3% | Mex$1,755.98 | Mex$633.60 | n/a | 15 |
Feb ’24 | n/a | Mex$1,269.95 0% | 19.3% | Mex$1,806.24 | Mex$595.87 | n/a | 15 |
Jan ’24 | n/a | Mex$1,170.54 0% | 21.8% | Mex$1,888.18 | Mex$622.91 | n/a | 15 |
Dec ’23 | n/a | Mex$1,162.26 0% | 22.5% | Mex$1,894.78 | Mex$625.08 | n/a | 14 |
Nov ’23 | n/a | Mex$1,224.27 0% | 21.5% | Mex$1,933.20 | Mex$637.76 | n/a | 14 |
Oct ’23 | n/a | Mex$1,212.40 0% | 22.7% | Mex$1,936.99 | Mex$599.07 | n/a | 14 |
Sep ’23 | n/a | Mex$1,217.37 0% | 23.6% | Mex$1,943.17 | Mex$600.98 | n/a | 13 |
Aug ’23 | n/a | Mex$1,178.31 0% | 28.0% | Mex$1,992.71 | Mex$534.13 | Mex$1,150.95 | 14 |
Jul ’23 | n/a | Mex$1,296.93 0% | 20.1% | Mex$1,950.42 | Mex$764.08 | n/a | 14 |
Jun ’23 | n/a | Mex$1,353.97 0% | 19.3% | Mex$1,935.19 | Mex$758.12 | n/a | 15 |
May ’23 | n/a | Mex$1,487.69 0% | 16.8% | Mex$1,944.45 | Mex$821.88 | n/a | 14 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.